Hosted on MSN2mon
FDA Adds Guillain-Barre Syndrome Warning to Two RSV Vaccines
The FDA issued a safety communication that warns about possible Guillain-Barré syndrome (GBS) with respiratory syncytial virus (RSV) vaccines manufactured by Pfizer (Abrysvo) and GSK (Arexvy).
MyChesCo on MSN4mon
GSK’s AREXVY Vaccine Shows Promising Results Across Three RSV Seasons
PHILADELPHIA, PA — GSK plc (LSE/NYSE: GSK) has released new data from the AReSVi-006 Phase III trial, demonstrating the ...
pharmaphorum5d
GSK to lean on Zhifei for Shingrix and maybe Arexvy in China
and may also call upon it to help it distribute new shot Arexvy. Herpes zoster vaccine Shingrix for shingles has been the main driver of GSK’s revenue growth for some time, accounting for £1.7 ...